Digital Power – DPW – Microcap Ripper!

Digital Power DPW is ripping to the upside today, up $0.25 (27+%) at $1.70 on reatlively heavy volume of six times the the prior 3 months average daily volume – and it’s not even mid-session yet.  Realize that this is a very thinly traded stock with only 60,000+ shares crossing the tape so far.

After setting a high above $2.20 in February 2004, the sellers took control with the stock settling into two-year range of roughly $0.50-0.80 to $1.60-1.80 on the upside.  A closing break above $1.70 sets in motion a potential test to $2.70-3.10 with a test of the February 2004 high area a conversative target. Keep this one on your board!

Aastrom Biosciences – ASTM – Boom!

As this is written ASTM is trading up $0.42 (23+%) at $2.21 after tagging $2.27 intraday on nearly 10 times the prior 3 months average daily volume – and the session isn’t over yet.  The FDA granted Aastrom orphan drug status for its Tissue Repair cells bone marrow treatment.  The key upside leve for this stock is the December 21, 2005 high of $2.53.  A close above $2.38 would be a positive technical development with a close above $2.53 setting up a potetnial move to last summer’s July high are of $3.30-3.55.  Above there the next key level is the 2005 high set in January above $4.30.  Keep this one on your board!

Generex Biotechnology – GNBT – Part Deux

The ole pop-n-drop played out in the final hour of trading Tuesday. After GNBT hit $3.35, it quickly popped back above $4.00 to $4.18 before the sellers took control again. A new session low was hit at $3.11, filling the real gap at $3.33-3.45 from March 20-21. Volume surged to over 80 million shares, 10 times the average daily volume for the prior 3 months. Two small real gaps remain below the market at 2.36-2.39 and 2.98-3.05. Note that Joe Investor was warned by the news of everyone jumping onboard Monday.

Generex Biotechnology – GNBT

Yesterday I warned about the runups in the “Avian Flu” stocks and that late to the party Joe Investor should be cautious. Today as I am writing this, GNBT tagged $5.02 intraday, its highest level since June 2002, and stagnated. The ensuing scramble for the exits once the selling started pushed the equity down to $3.35 so far. The breakout area was at 2.15-2.75 – look for support there.

The other five stocks mentioned, AVAN, CARN, GNBT, HEB, NVAX, VICL, were lower as well, though the 33+% drop in GNBT is the “winner”. A quick snapback above 4.00 would not be surprising as this stock begins to back-and-fill the recent runup move.

Avian Flu Concerns Continue to Support BioTechs – AVAN, CARN, GNBT, HEB, NVAX and VICL

Joe Investor continues to search for a way to make some cash on the current Avian Flu concerns. Recently, several equities have had sizable runups as money flows into this area. A few of the key players – or at least POTENTIAL players – are AVAN, CARN, GNBT, HEB, NVAX and VICL. They’ve all had substantial gains so coming late to the party now requires caution. Good luck!

Graphics Test

This is BOLD

This is graphics: